Robert Scoffin

Rob is an expert in the fields of molecular modeling and cheminformatics. His previous roles include CEO of Amedis and VP, Europe at CambridgeSoft. His DPhil is in Chemistry from the University of Oxford. Rob is passionate about applying computational methods to help meet medical challenges. He believes drug discovery and design can be streamlined and improved through the use of computational methods, resulting in better drugs being brought to market sooner. Rob is a Fellow of the Royal Society of Chemistry.